Novel fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same
US-2016296593-A1 · Oct 13, 2016 · US
Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same
US10155022B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10155022-B2 |
| Application number | US-201715666506-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 1, 2017 |
| Priority date | Jul 24, 2014 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The disclosure relates to a fat accumulation inhibitory peptide which essentially comprises an amino acid sequence represented by SEQ ID NO: 1, a pharmaceutical composition for preventing or treating obesity, which contains the peptide, and a health functional food for preventing or alleviating obesity, which contains the peptide. The fat accumulation inhibitory peptide according to the present invention has the function of inhibiting the differentiation of mesenchymal stem cells into adipocytes to thereby inhibit the accumulation of adipose tissue. Thus, the peptide according to the present invention is highly useful for the prevention or treatment of obesity.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating obesity, comprising administering a pharmaceutical composition which comprises the amino acid sequence represented by SEQ ID NO: 1 to a subject in need thereof. 2. The method of claim 1 , wherein the obesity is obesity caused by estrogen deficiency. 3. The method of claim 1 , wherein the pharmaceutical composition is administered by oral administration, injection administration, or local transplantation in the form of a gelling agent. 4. The method of claim 3 , wherein the gelling agent comprises a synthetic polymer or a natural polymer. 5. The method of claim 4 , wherein the synthetic polymer is any one selected from the group consisting of polylacticglycolic acid, poloxamer, and propylene glycol. 6. The method of claim 4 , wherein the natural polymer is any one selected from the group consisting of collagen, alginic acid, propylene glycol alginic acid, chondroitin sulfate, and chitosan. 7. The method of claim 1 , wherein the pharmaceutical composition is administered in an amount of 1-60 mg per kg of body weight of the subject in need thereof.
Assignees
Inventors
Classifications
Anorexiants; Antiobesity agents · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
having 5 to 11 amino acids · CPC title
by chemical synthesis · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10155022B2 cover?
- The disclosure relates to a fat accumulation inhibitory peptide which essentially comprises an amino acid sequence represented by SEQ ID NO: 1, a pharmaceutical composition for preventing or treating obesity, which contains the peptide, and a health functional food for preventing or alleviating obesity, which contains the peptide. The fat accumulation inhibitory peptide according to the present…
- Who is the assignee on this patent?
- Seoul Nat Univ R&Db Foundation, Nano Intelligent Biomedical Eng Corporation Co Ltd, Nano Intelligent Biomedical Eng Corporation Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K38/16. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).